St. Jude Medical's Allure Quadra pacemaker wins FDA OK

The FDA grants pre-market approval to St. Jude Medical's Allure Quadra cardiac resynchronization therapy pacemaker.

St. Jude Medical (NYSE:STJ) said its Allure Quadra pacemaker will be the 1st on the U.S. market to offer quadripolar cardiac resynchronization therapy after the FDA granted pre-market approval to the device.
Food & Drug Administration (FDA), St. Jude MedicalNews Well, Cardiac Rhythm Management, Pre-Market Approval (PMA), Regulatory/Complianceread more

Source: Mass Device - March 24, 2014 Category: Medical Equipment Authors: Brad Perriello Source Type: news